Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

7.65
Delayed Data
As of Mar 24
 +0.07 / +0.92%
Today’s Change
6.15
Today|||52-Week Range
9.88
-10.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash4.8M33.7M23.4M12.5M
 
 
 
 
 
Short Term Investment Cash3.0M28.9M-10.3M-10.9M
 
 
 
 
 
Cash & Short Term Investments4.8M33.7M23.4M12.5M
 
 
 
 
 
 
ReceivablesReceivables18.7M20.5M48.9M55.5M
 
 
 
 
 
 
InventoriesInventories2.3M2.6M5.1M6.3M
 
 
 
 
 
 
Current AssetsPrepaid Expenses1.1M1.1M----
 
 
 
Other Current Assets588.0K821.0K21.6M4.5M
 
 
 
 
 
Current Assets27.5M58.7M99.0M78.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross24.2M34.9M61.1M61.1M
 
 
 
 
 
Depreciation-14.5M-19.8M-26.5M-27.1M
 
 
 
 
 
Intangible Assets2.6M7.1M234.2M224.1M
 
 
 
 
 
Other Assets2.7M7.3M234.4M224.3M
 
 
 
 
 
Total Assets39.9M81.1M368.0M337.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.2M6.3M12.5M16.8M
 
 
 
 
 
Short Term Debt7.1M3.2M14.0M8.7M
 
 
 
 
 
Accrued Expenses741.0K1.2M7.4M4.2M
 
 
 
 
 
Other Current Liabilities741.0K1.2M7.4M4.2M
 
 
 
 
 
Other Liabilities14.3M14.6M40.1M38.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt3.3M5.3M57.4M97.4M
 
 
 
 
 
Deferred Taxes-588.0K-821.0K-32.4M-15.0M
 
 
 
 
 
Total Liabilities18.2M20.7M129.8M150.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.0028.6M22.9M
 
 
 
Common Equity21.7M60.4M209.5M163.7M
 
 
 
 
 
Total Shareholder Equity21.7M60.4M238.1M186.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding49.1M60.2M75.8M78.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.